Persisting lymphocyte deficiences during remission in Hodgkin's disease
- PMID: 302164
- PMCID: PMC1541004
Persisting lymphocyte deficiences during remission in Hodgkin's disease
Abstract
Blood lymphocytes from nineteen patients with Hodgkin's disease were tested in vitro before and after treatment. The patients were retested in complete and unmaintained remission at least 15 months after termination of radiotherapy. All patients except two had been treated with total nodal irradiation. The lymphocyte-DNA synthesis induced by concanavalin A (Con A) and PPD was poor and the spontaneous DNA synthesis was increased in untreated patients. Most patients had a T lymphocytopenia before treatment. After irradiation the total lymphocyte counts were reduced drastically. The number of T lymphocytes was particularly low, though the number of B lymphocytes decreased as well. However, the lymphocyte response to Con A and PPD remained low and unchanged. The results may suggest a persisting immunodeficiency in Hodgkin's disease as reflected by the lymphocyte response to Con A and PPD.
Similar articles
-
Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.Scand J Haematol. 1978 Apr;20(4):306-18. Scand J Haematol. 1978. PMID: 653310
-
[Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].Pathol Biol (Paris). 1978 Mar-Apr;26(3-4):159-62. Pathol Biol (Paris). 1978. PMID: 355984 French.
-
[Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].Sem Hop. 1978 Nov 8-15;54(37-40):1155-8. Sem Hop. 1978. PMID: 217096 French.
-
[Disorders of cellular immunity in Hodgkin's disease].Pol Arch Med Wewn. 1981 Aug;66(2):133-41. Pol Arch Med Wewn. 1981. PMID: 7033936 Review. Polish. No abstract available.
-
The nature and function of the Hodgkin's cell lectin and its role in lymphocyte agglutination.Int Rev Exp Pathol. 1992;33:115-40. doi: 10.1016/b978-0-12-364933-1.50010-2. Int Rev Exp Pathol. 1992. PMID: 1733869 Review. No abstract available.
Cited by
-
Immunity in Hodgkin's disease: status after 5 years' remission.Br J Cancer. 1982 Oct;46(4):593-600. doi: 10.1038/bjc.1982.243. Br J Cancer. 1982. PMID: 7138765 Free PMC article.
-
Checkpoint Inhibition in Hodgkin Lymphoma: Saving the Best for Last?Oncology (Williston Park). 2016 Oct 15;30(10):914-20. Oncology (Williston Park). 2016. PMID: 27753058 Free PMC article. Review.
-
Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study.Health Qual Life Outcomes. 2019 Jul 2;17(1):115. doi: 10.1186/s12955-019-1186-x. Health Qual Life Outcomes. 2019. PMID: 31266501 Free PMC article.
-
Prognostic effect of early diagnostic splenectomy in Hodgkin's disease: a randomized trial.Br J Cancer. 1980 Aug;42(2):284-91. doi: 10.1038/bjc.1980.228. Br J Cancer. 1980. PMID: 7426335 Free PMC article. Clinical Trial.
-
An intronic deletion in megakaryoblastic leukemia 1 is associated with hyperproliferation of B cells in triplets with Hodgkin lymphoma.Haematologica. 2020 May;105(5):1339-1350. doi: 10.3324/haematol.2019.216317. Epub 2019 Oct 3. Haematologica. 2020. PMID: 31582539 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources